Logo image of AWH

ASPIRA WOMEN'S HEALTH INC (AWH) Stock Fundamental Analysis

NASDAQ:AWH - Nasdaq - US04537Y2081 - Common Stock - Currency: USD

0.082  -0.01 (-12.49%)

After market: 0.0395 -0.04 (-51.83%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to AWH. AWH was compared to 191 industry peers in the Health Care Equipment & Supplies industry. AWH may be in some trouble as it scores bad on both profitability and health. While showing a medium growth rate, AWH is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year AWH has reported negative net income.
AWH had a negative operating cash flow in the past year.
AWH had negative earnings in each of the past 5 years.
AWH had a negative operating cash flow in each of the past 5 years.
AWH Yearly Net Income VS EBIT VS OCF VS FCFAWH Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 -10M -20M -30M

1.2 Ratios

AWH has a Return On Assets of -238.46%. This is amonst the worse of the industry: AWH underperforms 94.24% of its industry peers.
Industry RankSector Rank
ROA -238.46%
ROE N/A
ROIC N/A
ROA(3y)-220.38%
ROA(5y)-165.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
AWH Yearly ROA, ROE, ROICAWH Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K -1.5K -2K

1.3 Margins

AWH has a Gross Margin (59.67%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of AWH has grown nicely.
AWH does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 59.67%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.92%
GM growth 5Y17.69%
AWH Yearly Profit, Operating, Gross MarginsAWH Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -200 -400 -600 -800

More info and screens

0

2. Health

2.1 Basic Checks

AWH does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, AWH has more shares outstanding
AWH has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, AWH has a worse debt to assets ratio.
AWH Yearly Shares OutstandingAWH Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
AWH Yearly Total Debt VS Total AssetsAWH Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

2.2 Solvency

Based on the Altman-Z score of -143.66, we must say that AWH is in the distress zone and has some risk of bankruptcy.
The Altman-Z score of AWH (-143.66) is worse than 96.34% of its industry peers.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Altman-Z -143.66
ROIC/WACCN/A
WACC7.54%
AWH Yearly LT Debt VS Equity VS FCFAWH Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M

2.3 Liquidity

A Current Ratio of 0.76 indicates that AWH may have some problems paying its short term obligations.
AWH's Current ratio of 0.76 is on the low side compared to the rest of the industry. AWH is outperformed by 91.62% of its industry peers.
AWH has a Quick Ratio of 0.76. This is a bad value and indicates that AWH is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.71, AWH is doing worse than 87.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.76
Quick Ratio 0.71
AWH Yearly Current Assets VS Current LiabilitesAWH Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0 0 0 0

More info and screens

6

3. Growth

3.1 Past

AWH shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 44.50%, which is quite impressive.
Looking at the last year, AWH shows a small growth in Revenue. The Revenue has grown by 0.24% in the last year.
The Revenue has been growing by 15.13% on average over the past years. This is quite good.
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.01%
Revenue 1Y (TTM)0.24%
Revenue growth 3Y10.47%
Revenue growth 5Y15.13%
Sales Q2Q%10.28%

3.2 Future

AWH is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 32.55% yearly.
AWH is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 64.54% yearly.
EPS Next Y46.73%
EPS Next 2Y32.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year79.1%
Revenue Next 2Y89.68%
Revenue Next 3Y100.31%
Revenue Next 5Y64.54%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
AWH Yearly Revenue VS EstimatesAWH Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 50M 100M
AWH Yearly EPS VS EstimatesAWH Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2020 2021 2022 2023 2024 2025 2026 -2 -4 -6

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

AWH reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year AWH is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
AWH Price Earnings VS Forward Price EarningsAWH Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
AWH Per share dataAWH EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 -0.4 -0.6 -0.8

4.3 Compensation for Growth

AWH's earnings are expected to grow with 32.55% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y32.55%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for AWH!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ASPIRA WOMEN'S HEALTH INC

NASDAQ:AWH (4/16/2025, 8:00:01 PM)

After market: 0.0395 -0.04 (-51.83%)

0.082

-0.01 (-12.49%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-26 2025-03-26/amc
Earnings (Next)05-13 2025-05-13/bmo
Inst Owners10.64%
Inst Owner Change0%
Ins Owners13.72%
Ins Owner Change1.02%
Market Cap2.89M
Analysts80
Price Target5.61 (6741.46%)
Short Float %0.84%
Short Ratio0.04
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-18.81%
Min Revenue beat(2)-19.22%
Max Revenue beat(2)-18.41%
Revenue beat(4)0
Avg Revenue beat(4)-15.56%
Min Revenue beat(4)-19.22%
Max Revenue beat(4)-7.73%
Revenue beat(8)0
Avg Revenue beat(8)-15.76%
Revenue beat(12)0
Avg Revenue beat(12)-13.9%
Revenue beat(16)3
Avg Revenue beat(16)-9.34%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.31
P/FCF N/A
P/OCF N/A
P/B N/A
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-0.99
EYN/A
EPS(NY)-0.58
Fwd EYN/A
FCF(TTM)-0.34
FCFYN/A
OCF(TTM)-0.34
OCFYN/A
SpS0.26
BVpS-0.07
TBVpS-0.07
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -238.46%
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 59.67%
FCFM N/A
ROA(3y)-220.38%
ROA(5y)-165.91%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y9.92%
GM growth 5Y17.69%
F-Score4
Asset Turnover1.67
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 40.22%
Cap/Sales 0.4%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.76
Quick Ratio 0.71
Altman-Z -143.66
F-Score4
WACC7.54%
ROIC/WACCN/A
Cap/Depr(3y)46.91%
Cap/Depr(5y)76.44%
Cap/Sales(3y)1.16%
Cap/Sales(5y)3.33%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)44.5%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%72.01%
EPS Next Y46.73%
EPS Next 2Y32.55%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.24%
Revenue growth 3Y10.47%
Revenue growth 5Y15.13%
Sales Q2Q%10.28%
Revenue Next Year79.1%
Revenue Next 2Y89.68%
Revenue Next 3Y100.31%
Revenue Next 5Y64.54%
EBIT growth 1Y13.67%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y23.67%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y23.79%
OCF growth 3YN/A
OCF growth 5YN/A